share_log

EF Hutton Reiterates Buy on Innoviva, Maintains $22.5 Price Target

Benzinga ·  Mar 3, 2023 09:18

EF Hutton analyst Constantine Davides reiterates Innoviva (NASDAQ:INVA) with a Buy and maintains $22.5 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment